SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
20 hedge funds and large institutions have $3.66M invested in Seelos Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 15 closing their positions.
Holders
20
Holders Change
-9
Holders Change %
-31.03%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
12
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$1.6M |
2 |
2
BlackRock
New York
|
$908K |
3 |
3
Millennium Management
New York
|
$213K |
4 |
4
Jane Street
New York
|
$168K |
5 |
OAM
5
Oxford Asset Management
Oxford,
United Kingdom
|
$54K |